Brief: Protara Therapeutics Posts Q2 Loss Per Share $0.80
09/08/2022 14:51
Aug 9 (Reuters) - Protara Therapeutics Inc TARA.O :
* Q2 LOSS PER SHARE $0.80
* PROTARA THERAPEUTICS - CASH, CASH EQUIVALENTS AND
INVESTMENTS
POSITION OF $112.8M AS OF JUNE 30, 2022 EXPECTED TO FUND
OPERATIONS INTO MID-2024
* Q2 EARNINGS PER SHARE VIEW $-0.94 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX976kxt
Further company coverage: TARA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Protara Therapeutics
See all newsProtara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Protara Therapeutics Q2 net loss widens on higher expenses
Brief: Protara Therapeutics - Enters Sales Agreement With TD Cowen For Common Stock Offering
Brief: Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses
Protara Therapeutics Q1 net loss widens on higher expenses